How much funding has Maxona Pharmaceuticals raised?

Maxona Pharmaceuticals has disclosed $11.3M raised across 2 rounds.

Where is Maxona Pharmaceuticals headquartered?

Maxona Pharmaceuticals is headquartered in Malvern, US.

Maxona Pharmaceuticals

Malvern, US · Founded 2016 · Delaware corporation

MAXONA Pharmaceuticals develops non-opioid pain treatment options for the U.S. market. The company is focused on expanding therapeutic alternatives in pain management.

Biotech Healthtech Medical Devices

Founders & leadership

Shahin FatholahiExecutive

Richard BrandinExecutive

Shawn FatholahiinPresident & CEO

Board

David NakamuraBoard director

Behshad SheldonBoard director

Reported raises · per SEC filings

Form D private placements

$11.3M disclosed across 2 rounds · 2021–2025

▶$5.8MraisedAug 2026 · 56 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Shahin FatholahiExecutive Officer, Director
Behshad SheldonDirector
David NakamuraDirector
Richard BrandExecutive Officer

Offering amount: $12M
Amount sold: $5.8M
Sales commissions: $412.1K
Proceeds to insiders: $1M
Placement agents: Arcadia Securities, LLC
First sale: Jun 2025
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$5.6MraisedMay 2021 · 34 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

David NakamuraDirector
Behshad SheldonDirector
Shahin FatholahiExecutive Officer, Director

Offering amount: $10M
Amount sold: $5.6M
Sales commissions: $502.2K
Placement agents: Arcadia Securities, LLC
First sale: Apr 2021
Incorporated: Corporation, Delaware, 2016
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

King of Prussia firm raises $5.6M to advance non-opioid pain medicine portfolio – King of Prussia Districtvisitkop.com · Jun 2021

King of Prussia-based Maxona Pharmaceuticals Raises Millions in Private Sale to Advance Its Medication Portfoliomontco.today · May 2021

King of Prussia-based Maxona Pharmaceuticals raises $5.6M - Philadelphia Business Journalbizjournals.com · May 2021

Frequently asked questions

What does Maxona Pharmaceuticals do?: MAXONA Pharmaceuticals develops non-opioid pain treatment options for the U.S. market. The company is focused on expanding therapeutic alternatives in pain management.
How much funding has Maxona Pharmaceuticals raised?: Maxona Pharmaceuticals has disclosed $11.3M raised across 2 rounds.
Where is Maxona Pharmaceuticals headquartered?: Maxona Pharmaceuticals is headquartered in Malvern, US.